NOF CORPORATION reported revenue of ¥69.0 billion for the first quarter of the fiscal year ending March 2027, up 23.1% year on year, driven by growth in defense-related products in its chemical products business. However, operating profit fell to ¥10.7 billion and net income to ¥7.6 billion, affected by delays in shipments of DDS pharmaceutical formulation materials.
NOF CORPORATION released its results for the first quarter of the fiscal year ending March 2027. Revenue was ¥69.0 billion, up 23.1% year on year, marking a substantial increase.
However, operating profit fell to ¥10.7 billion and net income to ¥7.6 billion, affected by delays in shipments of DDS pharmaceutical formulation materials and other factors. Profit margins therefore continued to trend lower.
The company's recent earnings trend has shown signs of slowing over the past 12 quarters, and EPS momentum has also weakened. The date of the next earnings announcement has not been determined.